Successful implanted pacemaker for an extreme inhibitory reflex syncope evoked by post herpetic trigeminal neuralgia  by Quraishi, Muhammad Bilal et al.
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Syncope  is  deﬁned  as a transient  loss  of  consciousness  due  to  cerebral  hypoperfusion  characterized  by
rapid  onset,  short  duration,  and  spontaneous  complete  recovery.  Numerous  causes  of  syncope  have  been
described.  Vasovagal  syncope  is the  most  common  with  a number  of  precipitants.  We  report  a  case  of
post  herpetic  trigeminal  neuralgia  leading  to neurocardiogenic  syncope.  These  episodes  were  preceded
by severe  stabbing  left frontal  headaches  followed  by signiﬁcant  sinus  bradycardia,  asystole,  and  syncopeeuralgia
ost herpetic
yncope
requiring  pacemaker  implantation.  To our  knowledge  only  one  previous  case  of post  herpetic  trigeminal
neuralgia  leading  to syncope  has  been  reported.
<Learning  objective:  Neuralgia-associated  syncope  is a rare  phenomenon.  Failing  to  recognize  and  treat
appropriately  may  be  associated  with  recurring  episodes  of syncope  with  signiﬁcant  lifestyle  limitations.
Although  post  herpetic  neuralgia  is treatable,  one  should  be prepared  to insert  a pacemaker  if treatment
fails  to control  symptoms  that  progress  to  cardioinhibitory  syncope.>
© 2013  Japanese  College  of Cardiology.  Published  by Elsevier  Ltd.  All  rights  reserved.ntroduction
Syncope is deﬁned as a transient loss of consciousness due to
erebral hypoperfusion characterized by rapid onset, short dura-
ion, and spontaneous complete recovery [1]. Numerous causes
f syncope have been described. Vasovagal syncope is the most
ommon with a number of precipitants [2]. We  report a case of
ost herpetic trigeminal neuralgia leading to neurocardiogenic syn-
ope. These episodes were preceded by severe stabbing left frontal
eadaches followed by signiﬁcant sinus bradycardia, asystole, and
yncope. To our knowledge, only one previous case of post herpetic
rigeminal neuralgia leading to syncope has been reported.
ase report
We  report a case of a 72-year-old Caucasian male with his-
ory of diabetes, hypertension, and alcohol abuse who presented
o our facility complaining of left frontal headaches and episodes
f unconsciousness.
The patient reported that he had been diagnosed with
hingles involving the same symptoms a few months
∗ Corresponding author. Tel.: +1 408 507 3510; fax: +1 937 267 3915.
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878-5409/$ – see front matter © 2013 Japanese College of Cardiology. Published by Else
ttp://dx.doi.org/10.1016/j.jccase.2013.02.007previously and had been treated with aciclovir, prednisone,
and gabapentin. Earlier in the course of the disease he had
experienced severe pain which improved with the above-
mentioned treatment, however recently he had noticed a
recurrence.
The patient reported the pain was  so severe that he would “pass
out”.
The patient presented to our facility with a witnessed syn-
copal event. He was admitted and over the ensuing hours
had numerous paroxysms of left-sided frontal headaches fol-
lowed by marked bradycardia and asystole. The patient during
these paroxysms would complain of extreme pain over the left
frontal area followed by wincing, breath holding, and curling up
into a fetal position. The patient would subsequently lose con-
sciousness. After syncope, sinus bradycardia would return and
these episodes were witnessed by hospital staff and captured
on telemetry monitoring (Fig. 1). No seizure-like activity was
witnessed.
Computed tomography scan of the head and electrocardiogra-
phy were non-revealing. A neurologist was consulted and seizure
disorder was  ruled out. The dose of gabapentin was increased and
narcotics added to achieve pain control. He continued to experi-
ence paroxysm of pain accompanied with syncope. Due to repeated
syncopal events with documented sinus bradycardia and asystole,
a temporary pacemaker followed by a permanent pacemaker was
inserted.
vier Ltd. All rights reserved.
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sFig. 1. Upper electrocardiogram tracings showing sinus bradycardia w
Thereafter, the patient had no further episodes of syncope asso-
iated with post herpetic neuralgia.
iscussion
Approximately 40% of the general population experience at least
ne episode of syncope in their lifetime [3]. Reﬂex syncope is
he most frequent cause of syncope in any setting and age group
ccounting for 21% of all incidents [2]. Reﬂex syncope is further clas-
iﬁed as vasovagal, situational, carotid sinus syncope, and atypical
eﬂex syncope. Vasovagal syncope remains the most common type
1,3].
Three mechanisms have been described that are cardioin-
ibitory, vasodepressor, and mixed. The cardioinhibitory mecha-
ism is more common and mediated by increased parasympathetic
ctivation which in turn manifest as bradycardia, pauses, and
trioventricular blocks. The vasodepressor mechanism involves
ecreased activation of the sympathetic system, which leads to
ypotension. The third mechanism is mixed with syncope occur-
ing due to cardioinhibitory and vasodepressor responses [1,3].
Post herpetic neuralgia is a painful sequel of acute herpes zoster
nfection. Acute herpetic neuralgia is deﬁned as pain that occurs
ithin 30 days of rash onset. Pain that persists more than 30 days
fter the onset of the rash is called sub-acute herpetic neuralgia
hereas pain that persists beyond 120 days is called post herpetic
euralgia. The prevalence is estimated to be 500,000 to 1 million [4].
horacic dermatomes (T4–T6), ophthalmic division of trigeminal
erve, and cervical dermatomes are most commonly affected. The
ain of acute herpes zoster is a sharp stabbing sensation whereas
n post herpetic neuralgia the pain is described to be a burning
iscomfort. The pain maybe stimulus-dependent or -independent.
There is no direct relationship between post herpetic neuralgia
nd syncope, rather the association is indirect. The mechanism is
eﬂex syncope. In our case the patient experienced intense pain
enerating an exaggerated cardioinhibitory response leading to
systole and syncope.
Blood pressure is determined by cardiac output and peripheral
ascular resistance. Cardiac output in turn is a product of heart rate
nd stroke volume. Therefore, a signiﬁcant decrease in heart rate
ill lead to a reduction in cardiac output and hence blood pres-
ure. Only six to eight seconds of asystole is required to decrease
lood pressure to an extent to reduce cerebral perfusion and induce
yncope [1] (Fig. 1).
An argument can be made against the use of pacemakers as most
tudies showed mixed results. These studies used tilt table testingsystole. Lower electrocardiogram tracing showing temporary pacing.
to select patients for pacemakers. As a result, although vasovagal
syncope was  reproduced, it was  not an accurate reproduction of
real life syncope. The underlying rhythm at the time of syncope
was unknown. In these cases pacemakers failed to show any bene-
ﬁt as a decrease in heart rate was  not the sole mechanism and was
believed to be accompanied with hypotension [5–9]. An increase in
heart rate in most of these trials was ineffective. More focused stud-
ies like ISSUE-2 and 3 used internal loop recorders (ILR) for patients
with neurally mediated syncope with cardio inhibitory responses
[10,11]. The ILR was able to document heart rhythm at the time of
spontaneous syncope. Pacemakers in these trials showed a remark-
able reduction in syncopal episodes due to cardioinhibitory reﬂexes
predominated by asystolic pauses. This has led to recommenda-
tions by the European Society of Cardiology and the European
Heart Rhythm Association to assign a Class IIa for pacemakers
in patients older than 40 years and with documented cardioin-
hibitory mediated syncope [1]. In the past, permanent pacemakers
have been implanted in patients with syncope due to glos-
sopharyngeal neuralgia which can have an unpredictable course
[12,13].
To our knowledge this is the second case being reported of post
herpetic trigeminal neuralgia evoked reﬂex syncope [14]. Failing to
control the pain of post herpetic neuralgia and its relapsing, unpre-
dictable course and documented syncope with asystolic events
prompted the insertion of a pacemaker which was  justiﬁed by the
reasons cited above.
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